Ahmed Hamimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ahmed Hamimi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Haidy Megahed
Department of Family and Community Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA
2 shared publications - Joshua Brooks
Department of Radiology, University of Chicago, Chicago, IL 60637, USA
2 shared publications - Julia H. Miao
Department of Radiology, University of Chicago, Chicago, IL 60637, USA
2 shared publications - Ola A. E. Mohamed
Department of Radiology, Mayo Clinic, Rochester, MN, USA
2 shared publications - Ahmed M. Gharib
Biomedical and Metabolic Imaging Branch (BMIB), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892, USA
1 shared publication - Ashraf Naguib Etaby
Department of Diagnostic and Interventional Radiology, Faculty of Medicine, Alexandria University, Egypt
1 shared publication
Latest Publications
- Open Access
Can Artificial Intelligence Really Help? A Practicing Radiologist’s Simplified Guide to AI, with a Critical Appraisal of the Use of AI in Cancer-Associated Thromboembolism
Artificial intelligence (AI) has generated considerable excitement in radiology, with claims of transformative improvements in diagnostic accuracy, workflow efficiency, and clinical decision support. However, a critical gap persists between AI’s theoretical promise and its real-world performance, particularly in complex, high-stakes scenarios such as cancer-associated thromboembolism (CAT). CAT is a leading cause of morbidity and mortality in oncology patients, yet it remains underdiagnosed on routine imaging. This paper provides a general radiology critique of current AI applications, then narrows focus to CAT management. This review additionally evaluates AI’s role in incidental pulmonary embolism detection, risk stratification, and treatment decision support. While AI demonstrates sensitivity gains, it faces substantial limitations: data heterogeneity, lack of prospective validation, poor generalizability across cancer subtypes, and integration challenges with clinical workflows. Therefore, AI is not yet a reliable standalone tool for CAT management, but may serve as an adjunct if clinically validated, explainable, and embedded within multidisciplinary frameworks.
Open AccessCan Artificial Intelligence Really Help? A Practicing Radiologist’s Simplified Guide to AI, with a Critical Appraisal of the Use of AI in Cancer-Associated Thromboembolism
Artificial intelligence (AI) has generated considerable excitement in radiology, with claims of transformative improvements in diagnostic accuracy, workflow efficiency, and clinical decision support. However, a critical gap persists between AI’s theoretical promise and its real-world performance, particularly in complex, high-stakes scenarios such as cancer-associated thromboembolism (CAT). CAT is a leading cause of morbidity and mortality in oncology patients, yet it remains underdiagnosed on routine imaging. This paper provides a general radiology critique of current AI applications, then narrows focus to CAT management. This review additionally evaluates AI’s role in incidental pulmonary embolism detection, risk stratification, and treatment decision support. While AI demonstrates sensitivity gains, it faces substantial limitations: data heterogeneity, lack of prospective validation, poor generalizability across cancer subtypes, and integration challenges with clinical workflows. Therefore, AI is not yet a reliable standalone tool for CAT management, but may serve as an adjunct if clinically validated, explainable, and embedded within multidisciplinary frameworks.
- Open Access
When Cancer Clots: An Extensive Radiologic Analysis of Cancer-Associated Thromboembolism
Cancer-associated thrombosis (CAT) is a leading cause of morbidity and mortality in patients with malignancy, yet its imaging manifestations extend far beyond the conventional diagnosis of deep vein thrombosis and pulmonary embolism. This comprehensive review examines the full spectrum of CAT as encountered by radiologists, from routine venous thromboembolism to unusual-site thromboses, arterial thromboembolic events, catheter-related complications, and endovascular management strategies. Patients with cancer face a four- to seven-fold increased risk of venous thromboembolism compared with the general population, and arterial thromboembolism occurs at more than twice the expected rate, particularly within the first six months following cancer diagnosis. The radiologist’s role spans detection, characterization, and therapeutic guidance across multiple vascular territories. Key diagnostic challenges addressed include the distinction between bland and tumor thrombus—a determination with direct implications for TNM staging, surgical planning, and systemic therapy selection—and the recognition of incidental thromboembolism, which carries prognostic weight equivalent to symptomatic events and warrants similar clinical management. Emerging applications of diffusion-weighted MRI, contrast-enhanced ultrasound, and FDG-PET/CT provide a multiparametric toolkit for thrombus characterization, while artificial intelligence and machine learning show promise for improving patient selection and reducing unnecessary imaging. The expanding recognition of cancer-associated arterial disease, including cerebrovascular, coronary, and peripheral arterial events, requires that cardiovascular structures receive systematic attention on routine oncologic imaging. Interventional radiology contributes actively to CAT management through inferior vena cava filtration, catheter-directed thrombolysis, and thrombolytic-sparing mechanical thrombectomy, the latter being particularly relevant in oncology patients with elevated bleeding risk. Conclusions: Realizing the full potential of imaging in CAT requires not only technical proficiency with individual modalities but a synthesized, oncology-informed interpretive approach that incorporates the patient’s treatment history, biomarker status, and thrombotic risk profile at the time of image interpretation, positioning the radiologist as a central rather than peripheral figure in oncologic care.
Open AccessWhen Cancer Clots: An Extensive Radiologic Analysis of Cancer-Associated Thromboembolism
Cancer-associated thrombosis (CAT) is a leading cause of morbidity and mortality in patients with malignancy, yet its imaging manifestations extend far beyond the conventional diagnosis of deep vein thrombosis and pulmonary embolism. This comprehensive review examines the full spectrum of CAT as encountered by radiologists, from routine venous thromboembolism to unusual-site thromboses, arterial thromboembolic events, catheter-related complications, and endovascular management strategies. Patients with cancer face a four- to seven-fold increased risk of venous thromboembolism compared with the general population, and arterial thromboembolism occurs at more than twice the expected rate, particularly within the first six months following cancer diagnosis. The radiologist’s role spans detection, characterization, and therapeutic guidance across multiple vascular territories. Key diagnostic challenges addressed include the distinction between bland and tumor thrombus—a determination with direct implications for TNM staging, surgical planning, and systemic therapy selection—and the recognition of incidental thromboembolism, which carries prognostic weight equivalent to symptomatic events and warrants similar clinical management. Emerging applications of diffusion-weighted MRI, contrast-enhanced ultrasound, and FDG-PET/CT provide a multiparametric toolkit for thrombus characterization, while artificial intelligence and machine learning show promise for improving patient selection and reducing unnecessary imaging. The expanding recognition of cancer-associated arterial disease, including cerebrovascular, coronary, and peripheral arterial events, requires that cardiovascular structures receive systematic attention on routine oncologic imaging. Interventional radiology contributes actively to CAT management through inferior vena cava filtration, catheter-directed thrombolysis, and thrombolytic-sparing mechanical thrombectomy, the latter being particularly relevant in oncology patients with elevated bleeding risk. Conclusions: Realizing the full potential of imaging in CAT requires not only technical proficiency with individual modalities but a synthesized, oncology-informed interpretive approach that incorporates the patient’s treatment history, biomarker status, and thrombotic risk profile at the time of image interpretation, positioning the radiologist as a central rather than peripheral figure in oncologic care.
- 27 April 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (8) , 3184-3185
Building Bonds, One Birthday at a Time: A Low-cost Strategy to Enhance Workplace Cohesion
- 27 April 2026
- Published by Elsevier in Academic Radiology
- Vol. 33 (8) , 3184-3185
Building Bonds, One Birthday at a Time: A Low-cost Strategy to Enhance Workplace Cohesion
- 1 April 2024
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 6 (2) , e230102
Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease–Risk Persons Living with HIV
Purpose To assess early subclinical coronary artery disease (CAD) burden and its relation to myocardial function in asymptomatic persons living with HIV (PLWH) who are at low risk for cardiovascular disease (CVD). Materials and Methods In this prospective, HIPAA-compliant study (ClinicalTrials.gov NCT01656564 and NCT01399385) conducted from April 2010 to May 2013, 74 adult PLWH without known CVD and 25 matched healthy controls underwent coronary MRI to measure coronary vessel wall thickness (VWT) and echocardiography to assess left ventricular function. Univariable and multivariable linear regression analyses were used to evaluate statistical associations. Results For PLWH, the mean age was 49 years ± 11 (SD), and the median Framingham risk score was 3.2 (IQR, 0.5-6.6); for matched healthy controls, the mean age was 46 years ± 8 and Framingham risk score was 2.3 (IQR, 0.6-6.1). PLWH demonstrated significantly greater coronary artery VWT than did controls (1.47 mm ± 0.22 vs 1.34 mm ± 0.18; P = .006) and a higher left ventricular mass index (LVMI) (77 ± 16 vs 70 ± 13; P = .04). Compared with controls, PLWH showed altered association between coronary artery VWT and both E/A (ratio of left ventricular-filling peak blood flow velocity in early diastole [E wave] to that in late diastole [A wave]) (P = .03) and LVMI (P = .04). In the PLWH subgroup analysis, coronary artery VWT increase was associated with lower E/A (P < .001) and higher LVMI (P = .03), indicating restricted diastolic function. In addition, didanosine exposure was associated with increased coronary artery VWT and decreased E/A ratio. Conclusion Asymptomatic low-CVD-risk PLWH demonstrated increased coronary artery VWT in association with impaired diastolic function, which may be amenable to follow-up studies of coronary pathogenesis to identify potential effects on the myocardium and risk modification strategies. Keywords: Coronary Vessel Wall Thickness, Diastolic Function, HIV, MRI, Echocardiography, Atherosclerosis Clinical trial registration nos. NCT01656564 and NCT01399385 Supplemental material is available for this article. © RSNA, 2024.
- 1 April 2024
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 6 (2) , e230102
Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease–Risk Persons Living with HIV
Purpose To assess early subclinical coronary artery disease (CAD) burden and its relation to myocardial function in asymptomatic persons living with HIV (PLWH) who are at low risk for cardiovascular disease (CVD). Materials and Methods In this prospective, HIPAA-compliant study (ClinicalTrials.gov NCT01656564 and NCT01399385) conducted from April 2010 to May 2013, 74 adult PLWH without known CVD and 25 matched healthy controls underwent coronary MRI to measure coronary vessel wall thickness (VWT) and echocardiography to assess left ventricular function. Univariable and multivariable linear regression analyses were used to evaluate statistical associations. Results For PLWH, the mean age was 49 years ± 11 (SD), and the median Framingham risk score was 3.2 (IQR, 0.5-6.6); for matched healthy controls, the mean age was 46 years ± 8 and Framingham risk score was 2.3 (IQR, 0.6-6.1). PLWH demonstrated significantly greater coronary artery VWT than did controls (1.47 mm ± 0.22 vs 1.34 mm ± 0.18; P = .006) and a higher left ventricular mass index (LVMI) (77 ± 16 vs 70 ± 13; P = .04). Compared with controls, PLWH showed altered association between coronary artery VWT and both E/A (ratio of left ventricular-filling peak blood flow velocity in early diastole [E wave] to that in late diastole [A wave]) (P = .03) and LVMI (P = .04). In the PLWH subgroup analysis, coronary artery VWT increase was associated with lower E/A (P < .001) and higher LVMI (P = .03), indicating restricted diastolic function. In addition, didanosine exposure was associated with increased coronary artery VWT and decreased E/A ratio. Conclusion Asymptomatic low-CVD-risk PLWH demonstrated increased coronary artery VWT in association with impaired diastolic function, which may be amenable to follow-up studies of coronary pathogenesis to identify potential effects on the myocardium and risk modification strategies. Keywords: Coronary Vessel Wall Thickness, Diastolic Function, HIV, MRI, Echocardiography, Atherosclerosis Clinical trial registration nos. NCT01656564 and NCT01399385 Supplemental material is available for this article. © RSNA, 2024.
- Open Access
- 1 March 2016
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 47 (1) , 95-106
MERS-CoV: Middle East respiratory syndrome corona virus: Can radiology be of help? Initial single center experience
Human infection with a novel coronavirus named Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia and the Middle East in September, 2012. The aim of this study was to establish the most pathognomonic radiological sign(s) to diagnose MERS CoV. This is a retrospective descriptive study. All patients were subjected to serial X-ray. High resolution non-contrast CT chest was also obtained for 10 patients. The scans were reviewed for findings including consolidation, ground-glass opacities, nodules, reticular opacities and hilar and mediastinal adenopathy. A total of 12 patients were included in our study with prevalence of males (2:1) with ages ranging between 18 and 76 years having an average age of 36 ± 2 years. The outcome of these patients was as follows: 6 were treated with average hospital stay ranging between 21 and 35 days, one case died after 14 days, and 5 cases were transferred to Central Governmental hospital according the local authority rules. MERS CoV virus may have a specific pattern in chest X-ray and CT developing a single or multiple opacities progressing into a widespread multifocal bilateral patches of ground glass opacities or confluent consolidation resembling organizing pneumonia.
- 1 March 2016
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 47 (1) , 95-106
Open AccessMERS-CoV: Middle East respiratory syndrome corona virus: Can radiology be of help? Initial single center experience
Human infection with a novel coronavirus named Middle East respiratory syndrome coronavirus (MERS-CoV) was first identified in Saudi Arabia and the Middle East in September, 2012. The aim of this study was to establish the most pathognomonic radiological sign(s) to diagnose MERS CoV. This is a retrospective descriptive study. All patients were subjected to serial X-ray. High resolution non-contrast CT chest was also obtained for 10 patients. The scans were reviewed for findings including consolidation, ground-glass opacities, nodules, reticular opacities and hilar and mediastinal adenopathy. A total of 12 patients were included in our study with prevalence of males (2:1) with ages ranging between 18 and 76 years having an average age of 36 ± 2 years. The outcome of these patients was as follows: 6 were treated with average hospital stay ranging between 21 and 35 days, one case died after 14 days, and 5 cases were transferred to Central Governmental hospital according the local authority rules. MERS CoV virus may have a specific pattern in chest X-ray and CT developing a single or multiple opacities progressing into a widespread multifocal bilateral patches of ground glass opacities or confluent consolidation resembling organizing pneumonia.
- Open Access
- 1 December 2015
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 46 (4) , 1349-1355
What are the most reliable signs for the radiologic diagnosis of uterine adenomyosis? An ultrasound and MRI prospective
- 1 December 2015
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 46 (4) , 1349-1355
Open AccessWhat are the most reliable signs for the radiologic diagnosis of uterine adenomyosis? An ultrasound and MRI prospective
- Open Access
- 1 March 2015
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 46 (1) , 97-103
Osteoporotic or malignant vertebral fracture? This is the question. What can we do about it?
- 1 March 2015
- Published by Springer Nature in Egyptian Journal of Radiology and Nuclear Medicine
- Vol. 46 (1) , 97-103
Open AccessOsteoporotic or malignant vertebral fracture? This is the question. What can we do about it?
- Open Access
- 31 March 2013
- Published by Taylor & Francis in Alexandria Journal of Medicine
- Vol. 49 (1) , 49-55
Static fluid magnetic resonance urography in evaluation of ureteral ectopia: Experience in 10 pediatric cases
Ectopic ureters are often very difficult to diagnose with conventional imaging modalities especially in children. Magnetic resonance urography (MRU) has been recently investigated as a problem-solving tool for the evaluation of various congenital urogenital anomalies with favorable results. To assess the value of static fluid MRU in diagnosing ectopic ureters in childhood. Ten out of 14 pediatric patients with suspected ureteral ectopia (as suggested by clinical or conventional imaging techniques) were included in this study and prospectively studied by MRU aiming to confirm the suspected diagnosis. The examinations were done on 1.5T machines using static fluid T2W-MRU sequences. Ultrasound examinations were done for all patients. Voiding cystourethrogram (VCUG) was done for 8 patients to exclude vesico-ureteric reflux or urethral anomalies. All studied patients had dilated collecting systems. Static fluid MRU was able to detect the site of ectopic ureteric insertion in all 10 patients. It was superior to ultrasound in evaluation of 8 cases with complex duplex systems. In one patient with multiple congenital anomalies, MRU clearly demonstrated the urinary and extra-urinary anomalies. The final diagnosis was confirmed by surgical or endoscopic data in all patients. In dilated collecting systems, static fluid MRU can provide detailed assessment of the collecting systems and ureters as well as adequately detect ureteral ectopia. MRU should be recommended whenever a ureteric insertion anomaly is suspected.
- 31 March 2013
- Published by Taylor & Francis in Alexandria Journal of Medicine
- Vol. 49 (1) , 49-55
Open AccessStatic fluid magnetic resonance urography in evaluation of ureteral ectopia: Experience in 10 pediatric cases
Ectopic ureters are often very difficult to diagnose with conventional imaging modalities especially in children. Magnetic resonance urography (MRU) has been recently investigated as a problem-solving tool for the evaluation of various congenital urogenital anomalies with favorable results. To assess the value of static fluid MRU in diagnosing ectopic ureters in childhood. Ten out of 14 pediatric patients with suspected ureteral ectopia (as suggested by clinical or conventional imaging techniques) were included in this study and prospectively studied by MRU aiming to confirm the suspected diagnosis. The examinations were done on 1.5T machines using static fluid T2W-MRU sequences. Ultrasound examinations were done for all patients. Voiding cystourethrogram (VCUG) was done for 8 patients to exclude vesico-ureteric reflux or urethral anomalies. All studied patients had dilated collecting systems. Static fluid MRU was able to detect the site of ectopic ureteric insertion in all 10 patients. It was superior to ultrasound in evaluation of 8 cases with complex duplex systems. In one patient with multiple congenital anomalies, MRU clearly demonstrated the urinary and extra-urinary anomalies. The final diagnosis was confirmed by surgical or endoscopic data in all patients. In dilated collecting systems, static fluid MRU can provide detailed assessment of the collecting systems and ureters as well as adequately detect ureteral ectopia. MRU should be recommended whenever a ureteric insertion anomaly is suspected.
- 11 July 2012
- Published by Springer Nature in Neurosurgical Review
- Vol. 36 (1) , 87-97
Successful endovascular management of brain aneurysms presenting with mass effect and cranial nerve palsy
Aneurysms presented with mass effect are traditionally treated by surgical clipping to decompress their mass effect. The aim of this work is to discuss the efficiency of endovascular techniques in treating 47 patients with variable sizes of intracranial aneurysms presented with mass effect and/or cranial nerve palsy. There were 47 patients with 47 unruptured aneurysms. Group I includes 28 giant aneurysms; all are treated by parent vessel occlusion with or without intra-aneurysmal occlusion depending on anatomical locations. Group II includes 19 small and large aneurysms; all are treated by selective endosaccular occlusion with coils. Clinical presentations were ocular cranial nerve dysfunction (82.9%), optic nerve or chiasmatic dysfunction (21.2%), brain stem compression (8.5%), embolic (6%), epistaksis (4%), proptosis (2%), and bleeding per ear (2%). Out of 47 patients, symptoms were resolved in 31 cases (66%), improved in 10 cases (21%), and unchanged in six cases (13%). Out of 28 giant aneurysms, symptoms were resolved in 19 (68%), improved in four (14%), and unchanged in five (18%). Only four (14%) patients out of the 19 giant aneurysms with complete symptoms resolution showed significant mass reduction in MRI. Out of 19 non-giant aneurysm cases treated by selective endovascular occlusion with coils, symptoms were resolved in 12 cases (63%), improved in six (32%), and unchanged in one (5%). No complications from the treatment were observed. The longer the duration of symptoms before endovascular treatment is, the longer the duration till improvement or resolution postoperative in both groups. Recovery of aneurysm-induced mass effect occurs in most patients both after parent vessel occlusion and after selective coiling, and is comparable to results after surgical clipping. The improvement starts independent of aneurysmal shrinkage in postoperative MRI follow-ups. The arrest of pulsations and partial shrinkage within the aneurysms after endovascular treatment may be the logical reason behind neurological recovery.
- 11 July 2012
- Published by Springer Nature in Neurosurgical Review
- Vol. 36 (1) , 87-97
Successful endovascular management of brain aneurysms presenting with mass effect and cranial nerve palsy
Aneurysms presented with mass effect are traditionally treated by surgical clipping to decompress their mass effect. The aim of this work is to discuss the efficiency of endovascular techniques in treating 47 patients with variable sizes of intracranial aneurysms presented with mass effect and/or cranial nerve palsy. There were 47 patients with 47 unruptured aneurysms. Group I includes 28 giant aneurysms; all are treated by parent vessel occlusion with or without intra-aneurysmal occlusion depending on anatomical locations. Group II includes 19 small and large aneurysms; all are treated by selective endosaccular occlusion with coils. Clinical presentations were ocular cranial nerve dysfunction (82.9%), optic nerve or chiasmatic dysfunction (21.2%), brain stem compression (8.5%), embolic (6%), epistaksis (4%), proptosis (2%), and bleeding per ear (2%). Out of 47 patients, symptoms were resolved in 31 cases (66%), improved in 10 cases (21%), and unchanged in six cases (13%). Out of 28 giant aneurysms, symptoms were resolved in 19 (68%), improved in four (14%), and unchanged in five (18%). Only four (14%) patients out of the 19 giant aneurysms with complete symptoms resolution showed significant mass reduction in MRI. Out of 19 non-giant aneurysm cases treated by selective endovascular occlusion with coils, symptoms were resolved in 12 cases (63%), improved in six (32%), and unchanged in one (5%). No complications from the treatment were observed. The longer the duration of symptoms before endovascular treatment is, the longer the duration till improvement or resolution postoperative in both groups. Recovery of aneurysm-induced mass effect occurs in most patients both after parent vessel occlusion and after selective coiling, and is comparable to results after surgical clipping. The improvement starts independent of aneurysmal shrinkage in postoperative MRI follow-ups. The arrest of pulsations and partial shrinkage within the aneurysms after endovascular treatment may be the logical reason behind neurological recovery.